Lymphoma Non-Hodgkin Lymphoma: Copanlisib Rituximab Combination May Improve Survival By Jonathan Goodman, MPhil Publish Date June 11, 2021 Six patients experienced a grade 5 treatment-related adverse event.
Infection-Related Outcomes Relative to R-CHOP Dose in Older Patients With Diffuse Large B-Cell Lymphoma